F.A.A. Valster

845 total citations
4 papers, 76 citations indexed

About

F.A.A. Valster is a scholar working on Reproductive Medicine, Surgery and Genetics. According to data from OpenAlex, F.A.A. Valster has authored 4 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Reproductive Medicine, 1 paper in Surgery and 1 paper in Genetics. Recurrent topics in F.A.A. Valster's work include Ovarian cancer diagnosis and treatment (2 papers), Cancer, Lipids, and Metabolism (1 paper) and Intraperitoneal and Appendiceal Malignancies (1 paper). F.A.A. Valster is often cited by papers focused on Ovarian cancer diagnosis and treatment (2 papers), Cancer, Lipids, and Metabolism (1 paper) and Intraperitoneal and Appendiceal Malignancies (1 paper). F.A.A. Valster collaborates with scholars based in Netherlands. F.A.A. Valster's co-authors include Cornelis J.A. Punt, Nikki Knijn, J. Tol, Andrew Vincent, Linda Mol, Miriam Koopman, Alex L.T. Imholz, Steven Teerenstra, S.H. Goey and Maxime P. Look and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and European Journal of Obstetrics & Gynecology and Reproductive Biology.

In The Last Decade

F.A.A. Valster

4 papers receiving 74 citations

Peers

F.A.A. Valster

ONCOL

RM

SURGE

DERMA

OG

Ioannis Kotsopoulos United Kingdom

Maria Natale Italy

Pater Jl Canada

Simona Papi Italy

B. Linot France

A. Poveda Spain

María José Godes Spain

Magdalena Stankiewicz Poland

Magali Le Blanc‐Onfroy France

Charles-Briac Levaché France

Ioannis Kotsopoulos United Kingdom

F.A.A. Valster

34 ×0.7

ONCOL

25 ×1.0

RM

22 ×1.2

SURGE

5 ×0.3

DERMA

30 ×2.7

OG

Citations per year, relative to F.A.A. Valster F.A.A. Valster (= 1×) peers Ioannis Kotsopoulos

Countries citing papers authored by F.A.A. Valster

Since Specialization

Citations

This map shows the geographic impact of F.A.A. Valster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.A.A. Valster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.A.A. Valster more than expected).

Fields of papers citing papers by F.A.A. Valster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.A.A. Valster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.A.A. Valster. The network helps show where F.A.A. Valster may publish in the future.

Co-authorship network of co-authors of F.A.A. Valster

This figure shows the co-authorship network connecting the top 25 collaborators of F.A.A. Valster. A scholar is included among the top collaborators of F.A.A. Valster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.A.A. Valster. F.A.A. Valster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Burg, M.E.L. van der, Wendy Onstenk, Ingrid Boere, et al.. (2014). Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. European Journal of Cancer. 50(15). 2592–2601. 28 indexed citations

2.

Knijn, Nikki, J. Tol, Miriam Koopman, et al.. (2010). The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients. European Journal of Cancer. 47(3). 369–374. 39 indexed citations

3.

Burg, Matthias, Jan Janßen, Petronella B. Ottevanger, et al.. (2009). Multicenter randomized phase III trial of 3-weekly paclitaxel/platinum (PC3w) versus weekly paclitaxel/platinum (PCw) induction therapy followed by PC3w maintenance therapy in advanced epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 27(15_suppl). 5538–5538. 4 indexed citations

4.

Valster, F.A.A., et al.. (1990). Severe thrombocytopenia in a pregnant patient with platelet-associated IgM, and known von Willebrand's disease; a case report. European Journal of Obstetrics & Gynecology and Reproductive Biology. 36(1-2). 197–201. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact